Page last updated: 2024-08-22

rhenium and Carcinoma, Ductal, Breast

rhenium has been researched along with Carcinoma, Ductal, Breast in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleichrodt, R; Heider, KH; Koppe, M; Kuthan, H; Leeuwen, Pv; Roos, J; Schaijk, Fv	1
Biersack, HJ; Grünwald, F; Köhler, S; Krebs, D; Palmedo, H; Wagner, U	1

Other Studies

2 other study(ies) available for rhenium and Carcinoma, Ductal, Breast

Article	Year
Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancer. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:6 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Glycoproteins; Humans; Hyaluronan Receptors; Middle Aged; Prospective Studies; Radioimmunodetection; Radioisotopes; Rhenium; Safety	2004
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP. Clinical nuclear medicine, 1998, Volume: 23, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	1998

Article

Year

Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancer.

Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:6

Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Glycoproteins; Humans; Hyaluronan Receptors; Middle Aged; Prospective Studies; Radioimmunodetection; Radioisotopes; Rhenium; Safety

2004

Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.

Clinical nuclear medicine, 1998, Volume: 23, Issue:8

Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate

1998